Alx Oncology Holdings (ALXO): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 4,6 US Dollar | 3 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 138.276.997 | 6,11 | 7,52 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Alx Oncology Holdings
Mitarbeiter 48
Handelsplatz NASDAQ
Ticker Symbol ALXO
IPO Datum 2020-07-17
Adresse 323 Allerton Avenue, South San Francisco, CA, United States, 94080
Webseite https://www.alxoncology.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jason W. Lettmann | CEO & Director |
| 2 | Mr. Harish Shantharam C.F.A. | Chief Financial Officer |
| 3 | Ms. Shelly Wong CPA | Senior VP of Finance & Chief Accounting Officer |
| 4 | Dr. Barbara J. Klencke M.D. | Chief Medical Officer |
| 5 | Mr. Jeff E. Knight M.P.H. | Chief Development & Operating Officer |
| 6 | Mr. Michael Listgarten | General Counsel |
| 7 | Dr. Athanasios Tsiatis M.D. | Senior Vice President of Clinical Development |
| 8 | Dr. Lin Yeong-Liang M.D., M.S. | Senior Vice President of Drug Safety & Pharmacovigilance |
| 9 | Ms. Lisa Sauer | Senior Vice President of Regulatory Affairs & Quality Assurance |
| 10 | Ms. Sue Naim | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 9,41% | 27,07 Mio. USD |
| 2 | venBio Partners LLC | 9,32% | 26,80 Mio. USD |
| 3 | Redmile Group, LLC | 5,35% | 15,38 Mio. USD |
| 4 | Blackstone Inc | 4,21% | 12,12 Mio. USD |
| 5 | Driehaus Capital Management LLC | 4,15% | 11,93 Mio. USD |
| 6 | TCG Crossover Management, LLC | 4,09% | 11,76 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 3,02% | 8,69 Mio. USD |
| 8 | Marshall Wace Asset Management Ltd | 2,72% | 7,82 Mio. USD |
| 9 | Vivo Capital, LLC | 2,30% | 6,62 Mio. USD |
| 10 | Almitas Capital LLC | 2,30% | 6,60 Mio. USD |
| 11 | 5AM Venture Management, LLC | 2,21% | 6,36 Mio. USD |
| 12 | Orbimed Advisors LLC | 2,07% | 5,96 Mio. USD |
| 13 | Two Sigma Investments LLC | 1,15% | 3,30 Mio. USD |
| 14 | Millennium Management LLC | 1,12% | 3,21 Mio. USD |
| 15 | Susquehanna International Group, LLP | 0,96% | 2,76 Mio. USD |
| 16 | Acadian Asset Management LLC | 0,80% | 2,29 Mio. USD |
| 17 | Ensign Peak Advisors Inc | 0,69% | 1,98 Mio. USD |
| 18 | UBS Group AG | 0,66% | 1,90 Mio. USD |
| 19 | Renaissance Technologies Corp | 0,53% | 1,52 Mio. USD |
| 20 | Bank of America Corp | 0,42% | 1,20 Mio. USD |